Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kathryn Dahlgren

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Neurobiology of Learning and Memory|December 11, 2013
From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disordersMichael B VanElzakker, M Kathryn Dahlgren, F Caroline Davis, et al.
Experimental and Clinical Psychopharmacology|March 25, 2021
No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptomsStaci A Gruber, Rosemary T Smith, M Kathryn Dahlgren, et al.
JAMA Psychiatry|November 4, 2020
Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical TrialM Kathryn Dahlgren, Kelly A Sagar, Ashley M Lambros, et al.
Psychiatry Research. Neuroimaging|May 27, 2018
Prefrontal cortex activation during cognitive interference in nonsuicidal self-injuryM Kathryn Dahlgren, Jill M Hooley, Stephanie G Best, et al.
Drug and Alcohol Dependence|January 19, 2020
Recreational cannabis use impairs driving performance in the absence of acute intoxicationM Kathryn Dahlgren, Kelly A Sagar, Rosemary T Smith, et al.
Journal of the International Neuropsychological Society : JINS|July 15, 2021
An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary ResultsKelly A Sagar, M Kathryn Dahlgren, Ashley M Lambros, et al.
Plos One|June 9, 2016
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and MoodKelly A Sagar, M Kathryn Dahlgren, Megan T Racine, et al.
Menopause (New York, N.Y.)|August 2, 2022
A survey of medical cannabis use during perimenopause and postmenopauseM Kathryn Dahlgren, Celine El-Abboud, Ashley M Lambros, et al.
Journal of Psychiatric Research|January 9, 2022
Elevated striatal glutamate + glutamine in recreational cannabis users during abstinenceChun S Zuo, Katherine A Davis, Madeline K Kuppe, et al.
Scientific Reports|April 11, 2023
CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposureAshley M Lambros, Kelly A Sagar, M Kathryn Dahlgren, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neurobiology of Learning and Memory|December 11, 2013
From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disordersMichael B VanElzakker, M Kathryn Dahlgren, F Caroline Davis, et al.
Experimental and Clinical Psychopharmacology|March 25, 2021
No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptomsStaci A Gruber, Rosemary T Smith, M Kathryn Dahlgren, et al.
JAMA Psychiatry|November 4, 2020
Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical TrialM Kathryn Dahlgren, Kelly A Sagar, Ashley M Lambros, et al.
Psychiatry Research. Neuroimaging|May 27, 2018
Prefrontal cortex activation during cognitive interference in nonsuicidal self-injuryM Kathryn Dahlgren, Jill M Hooley, Stephanie G Best, et al.
Drug and Alcohol Dependence|January 19, 2020
Recreational cannabis use impairs driving performance in the absence of acute intoxicationM Kathryn Dahlgren, Kelly A Sagar, Rosemary T Smith, et al.
Journal of the International Neuropsychological Society : JINS|July 15, 2021
An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary ResultsKelly A Sagar, M Kathryn Dahlgren, Ashley M Lambros, et al.
Plos One|June 9, 2016
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and MoodKelly A Sagar, M Kathryn Dahlgren, Megan T Racine, et al.
Menopause (New York, N.Y.)|August 2, 2022
A survey of medical cannabis use during perimenopause and postmenopauseM Kathryn Dahlgren, Celine El-Abboud, Ashley M Lambros, et al.
Journal of Psychiatric Research|January 9, 2022
Elevated striatal glutamate + glutamine in recreational cannabis users during abstinenceChun S Zuo, Katherine A Davis, Madeline K Kuppe, et al.
Scientific Reports|April 11, 2023
CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposureAshley M Lambros, Kelly A Sagar, M Kathryn Dahlgren, et al.
Pageof 2